<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:usg="https://explorer.usaid.gov">
  <iati-identifier>US-GOV-1-7200AA21CA00033</iati-identifier>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="ES">Descubrimiento y exploraci&#xF3;n de pat&#xF3;geno emergentes - zoonosis virales (VZN PROFUNDOS)</narrative>
   <narrative xml:lang="EN">Discovery &amp; Exploration of Emerging Pathogens - Viral Zoonoses (DEEP VZN)</narrative>
   <narrative xml:lang="FR">D&#xE9;couverte et exploration des agents pathog&#xE8;nes naissants - les zoonoses virales (VZN PROFONDS)</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">DEEP VZN is a critical next step in the evolution of USAID&apos;s work to understand and address the risks posed by zoonotic diseases that can be transmitted from animals to humans. DEEP VZN will work in targeted countries in Africa, Asia, and Latin America that have both a high risk for viral spillover and the capacity to safely conduct viral discovery. Identifying and understanding unknown viral threats will help these countriesand the worldbe better prepared to detect, prevent and respond to future biological threats.</narrative>
   <narrative xml:lang="FR">VZN PROFOND est une prochaine &#xE9;tape critique dans l&apos;&#xE9;volution du travail d&apos;USAID pour comprendre et aborder les risques pos&#xE9;s par les maladies zoonotiques qui peuvent &#xEA;tre communiqu&#xE9;es des animaux &#xE0; des humains. VZN PROFOND fonctionnera dans les pays vis&#xE9;s en Afrique, en Asie, et en Am&#xE9;rique latine qui ont un &#xE0; haut risque pour le d&#xE9;bordement viral et la capacit&#xE9; pour conduire sans risque la d&#xE9;couverte virale. Les menaces virales inconnues de identification et de compr&#xE9;hension aideront ces le countriesand le worldbe plus bien pr&#xE9;par&#xE9; &#xE0; d&#xE9;tecter, emp&#xEA;cher et r&#xE9;pondre &#xE0; de futures menaces biologiques.</narrative>
   <narrative xml:lang="ES">VZN PROFUNDO es un paso siguiente cr&#xED;tico en la evoluci&#xF3;n del trabajo de USAID para entender y para dirigir los riesgos planteados por las enfermedades zoon&#xF3;ticas que se pueden transmitir de animales a los seres humanos. VZN PROFUNDO trabajar&#xE1; en los pa&#xED;ses apuntados en &#xC1;frica, Asia, y Am&#xE9;rica latina que tienen un de alto riesgo para el despilfarro viral y la capacidad conducir con seguridad descubrimiento viral. Las amenazas virales desconocidas de identificaci&#xF3;n y de comprensi&#xF3;n ayudar&#xE1;n este al countriesand el worldbe m&#xE1;s bien preparado a detectar, a prevenir y a responder a las amenazas biol&#xF3;gicas futuras.</narrative>
  </description>
  <participating-org ref="US-GOV-11" role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">Washington State University</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-10-01" type="1"></activity-date>
  <activity-date iso-date="2021-10-01" type="2"></activity-date>
  <activity-date iso-date="2026-09-30" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN"></narrative>
   </person-name>
   <telephone>+1 (202) 712 4810</telephone>
   <email>aidtransparency@usaid.gov</email>
   <website>https://www.usaid.gov/who-we-are/organization/bureaus/bureau-global-health</website>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <transaction ref="9DC52D4D3CD9">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">2000000</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="80D993346365">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-31"></transaction-date>
   <value currency="USD" value-date="2021-10-31">7883.39</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="25BEC80ED212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">18279.75</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="81D50A4E4BAF">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">32293.64</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="0B224E2A9409">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-02-28"></transaction-date>
   <value currency="USD" value-date="2022-02-28">114424.64</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="5AD01F7D299F">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">1218067.7</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="5AD01F7D299F">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">609033.85</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="5AD01F7D299F">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">609033.85</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="9F6B5245D520">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">259677.36</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="9F6B5245D520">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">519354.72</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="F698D6E77706">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-06-30"></transaction-date>
   <value currency="USD" value-date="2022-06-30">321401.68</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="KE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="877C66DFD50F">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">2000000</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="PE"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="3E416658B7DD">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">2000000</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="SN"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="82E25C25BC72">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">2000000</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="TH"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="A0C6B4DEFA11">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">2000000</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3004" vocabulary="99">
    <narrative xml:lang="EN">Pandemic Influenza and Other Emerging Threats (PIOET)</narrative>
   </sector>
   <recipient-country code="VN"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2021"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <conditions attached="0"></conditions>
  <usg:mechanism-signing-date iso-date="2021-10-01"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Kenya</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>10000000.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
